Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

FPC Capital Requirements

20 Jun 2013 07:08

RNS Number : 4621H
Royal Bank of Scotland Group PLC
20 June 2013
 



 

 

The Royal Bank of Scotland Group plc

 

20 June 2013

 

Statement on the completion of the UK Regulators capital shortfall exercise

 

The Royal Bank of Scotland Group plc ("RBS", "the Group") notes today's announcement by the Prudential Regulatory Authority ("PRA") on the completion of its capital shortfall exercise across major UK banks and building societies.

 

As indicated in its earlier release, dated 22 May, RBS expects to continue to improve its Core Tier 1 capital ("CT1") ratio during 2013 through continued delivery against its established business plan.

 

RBS continues to target a 'fully loaded' Basel 3 CT1 ratio of around 9% by year end 2013, after including the provision of capital to fund anticipated future loan growth.

 

Further details of RBS's plans and a reconciliation to the results published by the PRA today are provided below in the Appendix to this announcement.

 

For further information contact:

 

RBS Group Investor Relations

Richard O'Connor

Head of Investor Relations

+44 207 672 1758

RBS Group Media Relations

Michael Strachan

Deputy Head of Group Media Relations

+44 131 523 4205

 

Appendix to statement:

Reconciliation with RBS Group plc published ratios and 2013 glidepath

 

The PRA's original assessment of RBS's capital adequacy, under the FPC's recommendations, is outlined in the table below. RBS's position, factoring in business plans and actions announced at the FY12 results and Q113 IMS, is presented alongside this.

RBS's position takes into account the Group's previously announced repositioning of its Markets business and the planned continued reduction of Non-Core exposures, as well as other actions. While the Group's intention to partially IPO Citizens was announced in consideration of the PRA capital exercise, it is not factored into the 2013 capital actions.

The principal adjustments that RBS applied to the PRA December 2012 start point are:

1) the RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years, with acceptance expected prior to CRDIV implementation at the start of 2014;

2) Latest Capital Requirements Directive IV ("CRDIV") changes, which exempt EU corporates, pension funds and sovereign exposures from CVA volatility charge, confirmation of which was announced post the original PRA analysis.

By the end of 2013, the PRA capital requirement under the FPC exercise of £3.2bn is targeted to be reduced to £0.4bn. Several actions contribute to this including Markets downsizing, several small planned divestments and LME gains.

 

 

 

 

 

RBS capital requirements compared to PRA view

Reference

Per PRA

RBS

 

£bn

£bn

End 2012 position

Core Capital Resources (CET1 Basel 3)

37.2

Reported RWAs (Basel 3)

567.9

End 2012 CET1 Ratio

6.5%

Known capital adjustments

Note 2

1.0

Known/expected RWA adjustments

Note 3

(72.9)

Core Capital Resources (CET1 Basel 3)

38.2

Reported RWAs (Basel 3)

495.0

CET1 Ratio (as published by RBS)

Note 1

7.7%

PRA adjustments

PRA adjustments to capital resources for expected future losses and an assessment of future cost of conduct redress

(7.1)

(7.1)

PRA adjustments to RWAs to reflect a more prudent calculation of risk weights

56.3

56.3

Capital actions

Total CET1 equivalent of capital actions required of RBS

13.6

7.5

CET1 equivalent actions in RBS's plans

10.4

7.1

Additional capital action requirement planned by RBS to meet the PRA 7% as of December 2013

Note 4

3.2

0.4

 

 

Note 1: CET1 Basel 3 capital position as of December 2012

Reference

Capital

RWA

%

£bn

£bn

PRA

37.2

567.9

6.5%

Adjustments:

 

- Capital base changes

Note 2

1.0

0.2%

- Counterparty risk IMM model extension

Note 3

(47.0)

0.6%

- Reduction in counterparty risk due to CRDIV CVA changes

Note 3

(36.0)

0.5%

- Other

Note 3

10.1

(0.1)%

RBS (as published)

a

38.2

495

7.7%

 

 

a Note that Deferred Tax Asset deduction is taken in full: with an impact of 70bps on CT1. The real capital benefit of this asset for RBS will emerge over the next 5 years as the Group returns to profitability.

 

 

 

Note 2: The end 2012 capital base variance of £1bn is due to:

 

i) securitisation treated as RWAs rather than a deduction;

ii) offset principally by higher actual provisions taken in Q4 2012 for conduct risk relative to forecast used by the PRA.

 

Note 3: The RWA adjustment of £72.9bn represents RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years with approval expected shortly; and latest CRDIV changes reflected by RBS but not by the PRA given timing of the exercise. In addition, this also includes impact of securitisation treated as RWA rather than a deduction.

Reference

£bn

£bn

 

RWAs per PRA (Dec-12 Flash)

567.9

Counterparty risk IMM model extension

(47.0)

Reduction in counterparty risk due to CRDIV text changes

b

(36.0)

Net Other (including securitisation treated as RWA)

10.1

(72.9)

RWAs - as adjusted

495.0

 

 

Note 4: RBS actions to address remaining gap

Factoring in business plans announced at the FY12 results, Q113 IMS and remaining planned capital actions, RBS's capital shortfall reduces to £0.4bn, which the Group plans to fully satisfy in early 2014.

Reference

Per PRA

Per RBS

£bn

£bn

Total Capital actions required

13.6

7.5

Adjustments for models & EU exemptions

(6.1)

-

7.5

7.5

Q1 2013 progress on fully loaded ratio

(2.4)

Q2-Q4 2013 planned actions

RWA reduction (including Non Core rundown & Markets reshape)

(3.0)

Reduction in excess Expected Loss over provision

(1.0)

Other capital movements

c

(0.7)

Total Q2-Q4 2013 planned actions

(4.7)

Total 2013 actions

(7.1)

Post planned actions capital requirement

d

0.4

 

 

 

b CRDIV final text includes exemption for EU corporates, pension funds and sovereigns from CVA volatility charge in RWA calculations.

cCapital base movement includes, among other things, use of consensus profit forecast, expected gains on small disposals and liability management exercises.

d Remaining gap of £0.4bn to be closed through Q1 2014 profit generation and continuing benefits of Markets re-sizing. Planned IPO of Citizens provides further comfort.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKKDKABKKQAB
Date   Source Headline
31st Jan 20185:12 pmRNSTotal Voting Rights
29th Jan 20182:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20185:05 pmRNSPublication of Suppl.Prospcts
29th Dec 20171:20 pmRNSDirector/PDMR Shareholding
29th Dec 20171:20 pmRNSTotal Voting Rights
21st Dec 201710:14 amRNSSegmental Reporting Restatement Document
21st Dec 20179:00 amRNSDirectorate Change
7th Dec 20175:23 pmRNSPublication of a Prospectus
30th Nov 20173:29 pmRNSTotal Voting Rights
29th Nov 201711:51 amRNSHolding(s) in Company
28th Nov 20177:06 amRNS2017 Bank of England Stress Test Results
23rd Nov 20175:00 pmRNSDividend Declaration
21st Nov 20173:53 pmRNSUpdate on Ring-Fencing Plans
8th Nov 20174:34 pmRNSHolding(s) in Company
8th Nov 20173:28 pmRNSDirector/PDMR Shareholding
8th Nov 20172:40 pmRNSHolding(s) in Company
3rd Nov 201711:55 amRNSHolding(s) in Company
31st Oct 20171:41 pmRNSTotal Voting Rights
27th Oct 20174:17 pmRNSPublication of Suppl.Prospcts
27th Oct 20177:00 amRNSQ3 2017 Interim Management Statement
26th Oct 20172:13 pmRNSHolding(s) in Company
25th Oct 20171:53 pmRNSHolding(s) in Company
24th Oct 20175:37 pmRNSDisposal of shareholdings in Euroclear plc
24th Oct 20171:35 pmRNSHolding(s) in Company
24th Oct 201712:56 pmRNSHolding(s) in Company
20th Oct 201712:03 pmRNSHolding(s) in Company
17th Oct 20171:42 pmRNSHolding(s) in Company
10th Oct 20175:11 pmRNSNotices of Redemption
5th Oct 201712:24 pmRNSBlock listing Interim Review
29th Sep 20172:39 pmRNSTotal Voting Rights
29th Sep 20171:55 pmRNSThe Royal Bank of Scotland N.V. Interim Results
27th Sep 20176:20 pmRNSAllotment and Issue of New Ordinary Shares
26th Sep 20179:00 amRNSBank of America Merrill Lynch Conference
18th Sep 20175:15 pmRNSEC formally approves Alternative Remedies Package
18th Sep 20171:17 pmRNSHolding(s) in Company
14th Sep 20173:19 pmRNSHolding(s) in Company
11th Sep 20171:30 pmRNSBarclays Global Financial Services Conference
1st Sep 20172:35 pmRNSDirectorate Change
31st Aug 20179:50 amRNSTotal Voting Rights
23rd Aug 20176:11 pmRNSDividend Declaration
7th Aug 20175:43 pmRNSNotice of Redemption
7th Aug 20172:21 pmRNSPublication of Suppl.Prospcts
7th Aug 20177:00 amRNSRedemption of Non-cumulative Dollar Pref. Shares
4th Aug 20174:48 pmRNSRedemption of Non-cumulative Preference Shares
4th Aug 20177:20 amRNSTechnology & Innovation Committee
4th Aug 20177:00 amRNSHalf-year Report
31st Jul 20172:29 pmRNSTotal Voting Rights
26th Jul 20174:31 pmRNSUpdate on RBS's remaining State Aid obligation
12th Jul 20171:34 pmRNSSettlement reached with the FHFA re US RMBS claims
12th Jul 201711:00 amRNSTR-1 Notification of Major Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.